SCHEMBL5326801

SCHEMBL5326801

CCOC(=O)Cc1cnn(-c2ccccc2)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.53
HPGD P15428 3/20 0.53
MAPK1 P28482 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
P2RX7 Q99572 1/20 0.50
MAPT P10636 2/20 0.49
TP53 P04637 1/20 0.49
ALOX12 P18054 1/20 0.49
PDE4D Q08499 1/20 0.49
DRD2 P14416 1/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
SMO Q99835 1/20 0.48
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TSHR P16473 1/20 0.46
GAA P10253 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31584709 0.87 P2RX7 (0.54) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL1195016 0.84 MAPK1 (0.58) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL16839846 0.81 P2RX7 (0.47) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL31584574 0.81 P2RX7 (0.56) HPGDMAPK1SMN1; SMN2P2RX7MAPT
SCHEMBL5717585 0.81 MAPK1 (0.55) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL26328827 0.81 P2RX7 (0.42) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL12806554 0.80 SMO (0.59) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL1566895 0.79 ALDH1A1 (0.49) ALDH1A1HPGDMAPK1SMN1; SMN2P2RX7
SCHEMBL1065124 0.77 ALDH1A1 (0.75) ALDH1A1HPGDMAPK1SMN1; SMN2MAPT
SCHEMBL13688140 0.77 HPGD (0.42) ALDH1A1HPGDSMN1; SMN2P2RX7L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 ALDH1A1 2972/4885HPGD 1825/4885MAPK1 3183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.